These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 28960433)

  • 21. [Hepatitis virus and hepatocellular carcinoma].
    Rosmorduc O; Paterlini P; Poupon R; Brechot C
    Gastroenterol Clin Biol; 1999 Mar; 23(3):363-75. PubMed ID: 10384341
    [No Abstract]   [Full Text] [Related]  

  • 22. [Hepatitis viruses and hepatocarcinogenesis].
    Kaneko S; Unoura M; Kobayashi K
    Gan To Kagaku Ryoho; 1993 May; 20(7):858-63. PubMed ID: 8387755
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [HCV genome in type C hepatocellular carcinoma].
    Yamada G
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):777-81. PubMed ID: 7563874
    [No Abstract]   [Full Text] [Related]  

  • 24. Hepatitis C virus-related hepatocellular carcinoma and liver cirrhosis.
    Pecic V; Stankovic-Djordjevic D; Nestorovic M; Radojkovic M; Marjanovic H; Ilic B; Milojkovic M
    J BUON; 2011; 16(2):277-81. PubMed ID: 21766498
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Statin use and the risk of cirrhosis development in patients with hepatitis C virus infection.
    Yu ML
    J Hepatol; 2016 Apr; 64(4):981-2. PubMed ID: 26795827
    [No Abstract]   [Full Text] [Related]  

  • 26. Hepatocellular Carcinoma After Sustained Virologic Response: Leave No One Behind.
    Howell J; Thompson AJ
    Gastroenterology; 2017 May; 152(6):1282-1284. PubMed ID: 28363642
    [No Abstract]   [Full Text] [Related]  

  • 27. Viral pathogenesis of hepatocellular carcinoma in the United States.
    Liang TJ; Jeffers LJ; Reddy KR; De Medina M; Parker IT; Cheinquer H; Idrovo V; Rabassa A; Schiff ER
    Hepatology; 1993 Dec; 18(6):1326-33. PubMed ID: 8244256
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reply to "Statin use and the risk of cirrhosis development in patients with hepatitis C virus infection".
    Yang YH; Chen WC; Tsai YH; Chen PC
    J Hepatol; 2016 Apr; 64(4):982-3. PubMed ID: 26795832
    [No Abstract]   [Full Text] [Related]  

  • 29. Direct-Acting Antivirals Decreased Tumor Recurrence After Initial Treatment of Hepatitis C Virus-Related Hepatocellular Carcinoma.
    Ikeda K; Kawamura Y; Kobayashi M; Kominami Y; Fujiyama S; Sezaki H; Hosaka T; Akuta N; Saitoh S; Suzuki F; Suzuki Y; Arase Y; Kumada H
    Dig Dis Sci; 2017 Oct; 62(10):2932-2942. PubMed ID: 28884320
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Leading-edge research studies of hepatocellular carcinoma in Japan.
    Oda T
    Oncology; 2002; 62 Suppl 1():2-4. PubMed ID: 11868780
    [No Abstract]   [Full Text] [Related]  

  • 31. Risk factors for hepatocellular carcinoma in HCV-cirrhosis: what we know and what is missing.
    Fattovich G; Llovet JM
    J Hepatol; 2006 Jun; 44(6):1013-6. PubMed ID: 16678654
    [No Abstract]   [Full Text] [Related]  

  • 32. Characteristics of hepatocellular carcinoma in Japan.
    Kiyosawa K; Tanaka E
    Oncology; 2002; 62 Suppl 1():5-7. PubMed ID: 11868786
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatocellular carcinoma risk assessment by the measurement of liver stiffness variations in HCV cirrhotics treated with direct acting antivirals.
    Ravaioli F; Conti F; Brillanti S; Andreone P; Mazzella G; Buonfiglioli F; Serio I; Verrucchi G; Bacchi Reggiani ML; Colli A; Marasco G; Colecchia A; Festi D
    Dig Liver Dis; 2018 Jun; 50(6):573-579. PubMed ID: 29567413
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lack of evidence of an effect of direct-acting antivirals on the recurrence of hepatocellular carcinoma: Data from three ANRS cohorts.
    ANRS collaborative study group on hepatocellular carcinoma (ANRS CO22 HEPATHER, CO12 CirVir and CO23 CUPILT cohorts). Electronic address: stanislas.pol@aphp.fr
    J Hepatol; 2016 Oct; 65(4):734-740. PubMed ID: 27288051
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Next big threat for Pakistan Hepatocellular Carcinoma (HCC).
    Parkash O; Hamid S
    J Pak Med Assoc; 2016 Jun; 66(6):735-9. PubMed ID: 27339578
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [HCV infection among cirrhotic patients as a risk factor for generation of hepatocellular carcinoma: preliminary report].
    Kobayashi S; Nagai Y; Nakao T; Nogami H; Isono K
    Nihon Geka Gakkai Zasshi; 1991 Nov; 92(11):1666. PubMed ID: 1722866
    [No Abstract]   [Full Text] [Related]  

  • 37. A Rare Hepatic Tumor Mimicking Hepatocellular Carcinoma in a Patient With Hepatitis C Cirrhosis.
    Aasen T; Patel A; Patel NM
    Clin Gastroenterol Hepatol; 2016 Sep; 14(9):A29-30. PubMed ID: 27211497
    [No Abstract]   [Full Text] [Related]  

  • 38. The oncogenic hepatitis C virus and direct-acting antivirals: economic implications for hepatocellular carcinoma in Medicaid beneficiaries with cirrhosis.
    Mantravadi S
    Am J Manag Care; 2017 Apr; 23(5 Spec No.):SP180-SP184. PubMed ID: 28665676
    [No Abstract]   [Full Text] [Related]  

  • 39. [Prevalence of anti-HCV in sera of patients with hepatocellular carcinoma].
    Yu ZY
    Zhonghua Zhong Liu Za Zhi; 1993 Jan; 15(1):44-6. PubMed ID: 7687532
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Screening for hepatocellular carcinoma in high-risk patients: Western versus Eastern virus.
    Huo TI; Lee SD; Wu JC
    Hepatology; 2003 Jul; 38(1):269; author reply 270. PubMed ID: 12830012
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.